Patent ID: 8758729

Claim:
An oral composition, comprising: a. a polyguanidine compound of Formula (I): wherein: X denotes an orally acceptable counterion; Z is CH or N; R 1 , R 2 , and R 3 are each independently a hydrogen or a linear or branched, saturated or unsaturated, optionally hydroxylated C 1 to C 16 alkyl radical; A denotes a linear or branched, saturated or unsaturated, optionally hydroxylated C 1 to C 16 alkyl radical; or A denotes a linear or branched, saturated or unsaturated, C 1 to C 16 alkylene radical optionally substituted with at least one radical selected from the group consisting of: a hydroxyl, carboxyl, or carboxylate radical or a halogen; the alkylene radical optionally containing at least one function group selected from the group consisting of: an amine, ether, thioether, ester, amide, carbamate, urea, C 6 aryl or C 3 to C 8 cyclanyl ring optionally substituted with a C 1 -C 8 alkyl, hydroxyl or halogen; or A denotes one or more C 6 or C 7 aryl or C 5 to C 7 cyclanyl rings unsubstituted or substituted with a C 1 -C 8 alkyl, a hydroxyl group or a halogen; or A denotes a C 10 to C 14 polyaryl or C 6 to C 10 polycyclanyl chain, which may be interrupted with at least one function group selected from the group consisting of: a C 1 to C 8 alkylene radical, amine, amide, ether, thioether, hydrogen atom, carbamate or urea; and n denotes an integer between 2 and 5,000; b. an orally acceptable carrier; c. a bioacceptable glass composition comprising 40-60% SiO 2 , 10-30% CaO 2 , 10-35% Na 2 O, 2-8% P 2 O 5 , 0-25% CaF 2 , and 0-10% B 2 O 3 ; and d. a small particle silica having an average particle size of 0.01 μm-10 μm.